Home Biotech ETFs: 3 Questions For IShares Investing Expert
 

Keywords :   


Biotech ETFs: 3 Questions For IShares Investing Expert

2015-07-23 06:55:09| Biotech - Topix.net

TF investors in biotechnology stocks may be rattled by the nose-dive of the first heavyweight out of the earnings gate. , the $10 billion biotech exchange traded fund, has lost 0.8% in the past three trading sessions as 's reports this week, IBD spoke to Tushar Yadava, an iShares investment strategist, on whether the biotech sector has room to run: Tushar Yadava: Biotech investors entering for the first time are likely doing so in search of consistent growth - something the sector has delivered for a few years running.

Tags: questions expert investing biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 EVA 6
23.11 8
23.11SEVENTEEN ALWAYS YOURS Weverse 13
23.11 DX
23.11 No.23/1998
23.11 DVD 9
23.11
23.11 CD His Melody
More »